Personalized medicine enables targeted treatment for an individual at a molecular and pharmacogenomic level to maximize the effect of treatment. Organoids, derived from an individual’s stem cells, progenitor cells, or from induced pluripotent stem cells can be used for disease modeling, to test the efficiency and dosage of a drug, and for regenerative medicine—all at a personalized level.
Generate more predictive disease models to better understand disease behavior and develop more precise medical treatments
Generate more predictive disease models to better understand disease behavior and develop more precise medical treatments
Products for Personalized Medicine Research
Testimonials
Customer Success Stories
Using Organoids for Personalized Medicine
Using Organoids for Personalized Medicine
Watch an interview with Sylvia Boj from HUB as she discusses successful applications in disease modeling for personalized medicine.
Watch an interview with Sylvia Boj from HUB as she discusses successful applications in disease modeling for personalized medicine.
Learn More
Patient-derived Pancreatic Organoids to Deliver Personalized Treatments
Patient-derived Pancreatic Organoids to Deliver Personalized Treatments
Dr. Hervé Tiriac, associate project scientist at the University of California (UC), San Diego, discusses his role in creating a pancreatic organoid lab for testing.
Dr. Hervé Tiriac, associate project scientist at the University of California (UC), San Diego, discusses his role in creating a pancreatic organoid lab for testing.
Learn More
Human Tissue Chips
Human Tissue Chips
Disover Dr. Kacey Ronaldson-Bouchard’s point of view on adapting cell based assays to “patient-in-a-dish” systems.
Disover Dr. Kacey Ronaldson-Bouchard’s point of view on adapting cell based assays to “patient-in-a-dish” systems.
Learn More
Scaling Up With Spheroids
Scaling Up With Spheroids
See how researchers at Uppsala University in Sweden develop innovative quiescent spheroid cell models and a unique process of high throughput screening.
See how researchers at Uppsala University in Sweden develop innovative quiescent spheroid cell models and a unique process of high throughput screening.
Learn MoreFeatured Resources
CRISPR and Cytotoxicty Against Cancer Cells
Read more about an approach using CRISPR/Cas9 mediated immune technology that revolutionizes genomic editing by enabling RNA-guided, site-specific DNA cleavage with high efficiency, which holds a great potential for curing disease.
3D Models and Human Pancreatic Cancer
Discover how 3D models are being explored such as neoplastic pancreatic organoids that better mimic in vivo physiology and are thought to be better predictors for compound profiling.
支持
技术支持——设定新的行业标准
技术支持——设定新的行业标准
技术支持——设定新的行业标准
了解更多我们致力于确保您成功完成细胞培养，而且在成交之后我们仍会继续提供优质服务。康宁专家团队会不断完善我们的工具，推动您探索新发现，随时为您研究的每一步提供鼎力支持。需要我们帮助您选择合适的表面？正在处理复杂的细胞？需要定制功能？通过建立合作伙伴关系，康宁可以帮助您解决各种具体难题。随时随地满足所需——康宁是值得您完全信赖的合作伙伴，可确保您选择适当的实验室研发工具。
我们致力于确保您成功完成细胞培养，而且在成交之后我们仍会继续提供优质服务。康宁专家团队会不断完善我们的工具，推动您探索新发现，随时为您研究的每一步提供鼎力支持。需要我们帮助您选择合适的表面？正在处理复杂的细胞？需要定制功能？通过建立合作伙伴关系，康宁可以帮助您解决各种具体难题。随时随地满足所需——康宁是值得您完全信赖的合作伙伴，可确保您选择适当的实验室研发工具。
联系我们